Why is the Creso Pharma (ASX:CPH) share price frozen today?

Creso is once again in a trading halt…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) enjoyed a very pleasing day of gains on Tuesday. The All Ords finished the day up 0.33% at 7,587.4 points. But one ASX share wasn't even trading today. That would be the Creso Pharma Ltd (ASX: CPH) share price.

Creso shares closed at a share price of 9.6 cents yesterday afternoon. And that's where they will be staying, at least for a while.

That's because Creso announced that it has requested a trading halt, effective this morning. The company has said that this precedes it "releasing an announcement", with the shares to remain halted until this announcement is made public, or until 2 December (Thursday this week).

And that's all we know for now.

A dollar sign embedded in ice, indicating a share price freeze or trading halt

Image source: Getty Images

Creso shares notch third ASX trading halt for November

But this isn't Creso's first rodeo, as it were. This ASX cannabis share was also placed in a trading halt just last week on 23 November. Before that, there was another halt, that one on 16 November.

The latter was sparked by an ASX 'speeding ticket' after the company fell more than 9% that day. My Fool colleague Mitchell dived deeper into this at the time.

The former halt was initiated in order for the company to inform investors that the Australian Securities and Investments Commission (ASIC) had requested Creso to "produce certain documents to ASIC in connection with an ASIC investigation".

This notice also informed the market that "ASIC's investigation includes suspected contraventions by the Company [Creso], its officers, agents, employees and representatives in relation to trading in its securities". Creso stressed that "it should not be construed as an indication by ASIC that a contravention of the law has occurred, nor should it be considered a reflection upon any person or entity".

So today's announcement means that it is the third such trading halt Creso has experienced over just the month of November.

Given that the last two halts didn't contain much in the way of good news, shareholders will likely be nervously awaiting what the company has to say next.

Until then, it doesn't look like the Creso share price will be available for public trading.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Young businesswoman sitting in kitchen and working on laptop.
Healthcare Shares

Up 15% in a week, is it too late to buy rebounding CSL shares?

CSL shares trade on roughly 13 times forecast FY26 earnings and offer a good dividend yield.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

Young woman thinking with laptop open.
Healthcare Shares

Why are Sigma Healthcare shares in the spotlight this week?

Is the latest sell-off overdone?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is it time to get greedy with Pro Medicus shares?

The company was swept up in the huge sector-wide downturn in late 2025 and early 2026 as investors turned their…

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development.
Healthcare Shares

Prediction: I think Telix shares could double in value in 2026. Here's why

The biopharmaceutical company's shares dipped to a three-year low in February, but have now rebounded strongly.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

How much does UBS think CSL will bounce back?

If the worst is over, what's the upside for the shares?

Read more »

Woman with long hair smiles for the camera.
Healthcare Shares

Why I'd buy CSL shares while sentiment is weak

The market no longer treats this ASX healthcare giant as flawless, and that may make the investment case more interesting.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is this exciting healthcare stock a buy, hold or sell after rocketing 16% yesterday?

Can this soaring stock keep rising?

Read more »